Stocksigma LogoStocksigma Logo

Solara Active Pharma Reports Strong Q2 FY27 Results with PAT at Rs 28.46 Cr

Solara Active Pharma Sciences reported consolidated revenue from operations of Rs 417.34 Cr for the quarter ended 30th Sep'26, up 33.1% YoY from Rs 313.54

Solara Active Pharma Reports Strong Q2 FY27 Results with PAT at Rs 28.46 Cr

Solara Active Pharma Sciences Ltd 路 Financial Result 路 16 Oct 2026, 7:08 pm

Solara Active Pharma Reports Strong Q2 FY27 Results with PAT at Rs 28.46 Cr Solara Active Pharma Sciences reported consolidated revenue from operations of Rs 417.34 Cr for the quarter ended 30th Sep'26, up 33.1% YoY from Rs 313.54 Cr and 9.4% QoQ from Rs 381.60 Cr. Profit after tax stood at Rs 28.46 Cr, swinging from a net loss of Rs 10.10 Cr in the prior-year period, despite an exceptional loss of Rs 4.50 Cr on the sale of mothballed Vizag plant CWIP. Basic EPS reached Rs 5.92. Cumulative rights issue collections stood at Rs 446.62 Cr.

Original exchange filing (PDF)

More announcements from Solara Active Pharma Sciences Ltd

All Solara Active Pharma Sciences Ltd announcements